estimate of the concentration of BE in the urine, although in screening programs it is generally used only to detect the presence or absence of BE. As part of a larger study, we had the unique opportunity to answer these practical questions as they relate to cocaine.
Materials and Methods
Sixteen surgical patients (11) received cocaine as a vasoconstrictor before nasal intubation or before nasal surgery. Three of these underwent cardiovascular surgery (cardiovascular patients), 11 underwent dental surgery (dental patients), and two underwent nasal surgery. The three volunteers were all men who had used cocaine previously for recreational purposes. Both the patients and the volunteers were fully informed about the study and agreed to participate.
A solution of cocaine hydrochloride (100 g/liter) was applied topically to the nasal mucosa of the cardiovascular patients, dental patients, and the volunteers. The nasal surgery patients received crystalline cocaine hydrochloride applied topically to the nasal mucosa with a cotton applicator wetted with isotonic saline. One additional injected over 1 mm. Doses in the surgical patients were 1.5 to 1.7 mg/kg of body weight (total of 75 to 130 mg); doses in the volunteers ranged between 0.19 and 1.5 mg/kg of body weight (total of 13 to 108 mg). The volunteers received no other drugs. However, the surgical patients received diazepam (10 mg/70 kg of body weight) and morphine sulfate (10 mg/70 kg of body weight) intramuscularly 1 h before induction of general anesthesia. The cardiovascular patients were given dia.zepam or sodium pentothal and either succinylcholine or pancuronium bromide intravenously for muscle relaxation, while the dental and nasal surgery patients were given sodium pentothal and succinylcholine intravenously. All surgical patients received nitrous oxide and halothane as maintenance anesthetics. We obtained double-voided (i.e., collected 15 mm after a preliminary voiding) urine specimens before cocaine administration and at intervals afterwards for as long as was practical, in some patients as long as 84 h. NQ samples were collected from cardiovascular patients after they were placed on cardiopulmonary bypass because the associated hemodilution would have rendered subsequent data on urinary concentrations of BE invalid. For this reason we do not have urine specimens on cardiovascular patients beyond 3 h. Twentymilliliter samples of urine were collected in glass bottles and frozen (-15 #{176}C) immediately afterwards. All samples from each experiment were analyzed on the same day. We did EMIT analyses according to the manufacturer's instructions, using the Syva assembled system, which consists of a Model 300-N spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, Ohio 44074) equipped with a thermostated cuvette (Model 3017), automatic pipettor-dilutor (Cavro Scientific Instruments, Los Altos, Calif.), and programmed calculator. In this procedure urine, a bacterial suspension, lysozyme covalently bonded to BE, and an anti-BE antibody are used, and the absorbance change at 436 nm is monitored at 37 #{176}C for 40 s. If BE is present, enzyme/bacteria complex is displaced from the antibody and the turbid bacterial substrate clears. Standard curves were prepared over the range of 0-10 mg/liter. Because the upper limit of linearity varied between reagent lots, specimens with concentrations greater than the highest linear standard point were repeated after dilutions. As the manufacturer recommends, concentrations <1.0 mg/liter were considered negative. The manufacturer-supplied antibody to BE used in this study shows only minimal cross reactivity with ecgonine and cocaine, and measurements are therefore assumed here to reflect concentrations of BE, although there may be traces of other metabolites, as yet unverified, that cross react.
Results
The surgical patients (with the exception of dental patient No. 7) and volunteers who received intranasal cocaine all showed a similar pattern of urinary excretion of BE (Table 1 ). All urines obtained before administration of cocaine were negative for BE. A positive test for BE occurred by 1 to 4 h and persisted for as long as 27 h after drug administration.
The urines then were, with a single exception, negative and continued to be negative when followed for as long as 84 h. In 17 of 19 subjects who received intranasal cocaine, concentrations of BE in the urine became maximal within the first 12 h after drug administration, then decreased. In the surgical patients who received 1.5 to 1.7 mg/kg of cocaine, the average peak concentration was 9 mg/liter (±2 mg/liter SE) and occurred 10.6 h (±0.9 h, SE) after intranasal application.
In the volunteers who received cocaine intranasally, peak concentrations of BE in the urine were dose dependent (Figure 1 ). The smallest dose (0.19 mg/kg; total dose, 13 mg), administered to volunteer No. 18a, resulted in a low concentration of BE, close to the minimal concentration detectable by the EMIT method. There was no difference in the pattern of excretion between males and females. Surgical patient No. 7 differed from the common pattern in that BE was found in her urine for 46 h after drug administration.
We had the opportunity to analyze urine samples from a single volunteer who received intravenous cocaine (Table 1) . These data are too limited for valid comparison with that after intranasal application. However, topical application of cocaine is the most common form of illicit use, and so is more relevant to the concerns of drug-dependency treatment programs.
Discussion
A similar temporal pattern of excretion was reported by Schneider et al. (12) , who used a different assay technique to study five patients who had received an unspecified quantity of cocaine.
Using gas chromatography, Wallace et al. (7) found high BE concentrations within 8 h of intranasal application of 250 mg of cocaine to each of 10 patients who were undergoing nasal surgery. Their total dosage was much higher than our (or probable illicit "street") dosages. Although they said that specimens were also analyzed by the EMIT technique, the data were not presented. In any event, the EMIT procedure is by far the most widely used method of screening urines for cocaine use, and the relation of findings by this procedure to time and dose should be studied and known.
Our data are subject to a number of limitations. We did not have continuous urine samples, and so we inadvertently may have missed higher peak concentrations, or some urines may have remained positive for BE a few hours longer than our last positive sample. Although the use of other drugs theoretically could have affected the metabolism of cocaine in surgical patients, they showed a pattern similar to that of our volunteers, who did not receive other drugs. Our data are also subject to all the limitations of analyses of constituents in single casual (i.e., untimed) urine specimens as well as the semiquantitative nature of the analytical procedure. Fluctuations in urinary pH and volume will, of course, affect the concentrations of a drug in a specimen of urine. Conclusions concerning the pharmacokinetics of cocaine thus cannot be drawn from our data. Rather, our data are intended as a guide for those involved with drug-abuse screening programs that rely on the EMIT analysis for detection of cocaine use. Specimens are received by such laboratories for purposes of screening for drugs of abuse as casual urine specimens. No attempt is made to control for urinary pH, creatinine concentration, or volume. Treatment programs use such data to determine if a drug has been used, and how recently it has (or has not) been used. They also wish to know the likelihood of detecting usage relative to the frequency of testing.
The doses used in both patients and volunteers in our study are similar to those used illicitly, and our results are applicable to drug-screening programs. Our data indicate that if cocaine is used topically, in a dose range of 13 to 130 mg, and BE is tested for by the EMIT procedure, results will be positive within 1 to 4 h of a single application, will peak at about 10 to 12 h, remain positive for 18 to 27 h, and will after about 27 h be negative. If BE is found it can be concluded with reasonable confidence that cocaine has been used within the last 27 h. Repeated positives over intervals greater than 27 h are more consistent with repeated use than when there is only residual excretion of metabolites from a single dose. These factors should be considered by drug-dependency treatment programs when results of urine screening for cocaine use by the EMIT procedure are evaluated.
